Addus HomeCare Co. (NASDAQ:ADUS) Holdings Lifted by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. boosted its holdings in Addus HomeCare Co. (NASDAQ:ADUSFree Report) by 1.2% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 65,113 shares of the company’s stock after acquiring an additional 802 shares during the quarter. Harbor Capital Advisors Inc. owned about 0.36% of Addus HomeCare worth $8,162,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Wasatch Advisors LP boosted its holdings in Addus HomeCare by 11.8% during the third quarter. Wasatch Advisors LP now owns 1,043,240 shares of the company’s stock worth $138,782,000 after buying an additional 110,010 shares in the last quarter. Point72 Asset Management L.P. boosted its position in shares of Addus HomeCare by 73.4% in the 2nd quarter. Point72 Asset Management L.P. now owns 745,824 shares of the company’s stock valued at $86,598,000 after purchasing an additional 315,602 shares during the period. Dimensional Fund Advisors LP increased its stake in Addus HomeCare by 0.8% in the 2nd quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after purchasing an additional 5,421 shares in the last quarter. State Street Corp raised its holdings in Addus HomeCare by 4.4% during the 3rd quarter. State Street Corp now owns 663,610 shares of the company’s stock worth $88,280,000 after buying an additional 27,990 shares during the period. Finally, Principal Financial Group Inc. lifted its stake in Addus HomeCare by 17.5% during the third quarter. Principal Financial Group Inc. now owns 505,853 shares of the company’s stock valued at $67,293,000 after buying an additional 75,409 shares in the last quarter. 95.35% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Addus HomeCare

In related news, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the sale, the chief executive officer now directly owns 141,897 shares in the company, valued at $17,476,034.52. This represents a 8.10 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction on Monday, December 9th. The shares were sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the transaction, the executive vice president now owns 10,217 shares of the company’s stock, valued at approximately $1,236,257. The trade was a 18.05 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 39,750 shares of company stock valued at $4,930,750. 4.60% of the stock is currently owned by company insiders.

Addus HomeCare Trading Down 1.2 %

NASDAQ ADUS traded down $1.58 on Friday, reaching $124.84. The company’s stock had a trading volume of 43,458 shares, compared to its average volume of 121,477. Addus HomeCare Co. has a 52 week low of $85.94 and a 52 week high of $136.12. The firm has a market cap of $2.26 billion, a PE ratio of 28.57, a price-to-earnings-growth ratio of 2.11 and a beta of 1.00. The business has a 50-day moving average price of $125.04 and a 200 day moving average price of $125.95.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last issued its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The business had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. During the same period in the prior year, the firm posted $1.03 EPS. Addus HomeCare’s quarterly revenue was up 7.1% compared to the same quarter last year. Analysts anticipate that Addus HomeCare Co. will post 4.59 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on ADUS shares. Macquarie reissued an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a research report on Monday, November 4th. Oppenheimer boosted their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a research note on Monday, September 23rd. KeyCorp assumed coverage on Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 price objective for the company. Citizens Jmp raised Addus HomeCare to a “strong-buy” rating in a research note on Monday, December 16th. Finally, Stephens increased their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research report on Wednesday, November 6th. One research analyst has rated the stock with a sell rating, nine have issued a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $133.67.

Read Our Latest Report on Addus HomeCare

Addus HomeCare Profile

(Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Recommended Stories

Institutional Ownership by Quarter for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.